Clinical Trials Browser

Phase 1 × Solid Tumors × ARQ 197 × Clear all

NCT01149720 2019-02-12

Determination of the Relative Bioavailability of ARQ 197 Tablet Formulation With Capsule C Formulation as a Reference in Subjects With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT01699061 2019-02-12

Effect of Tivantinib on the QTC Interval in Cancer Subjects

Phase 1 Completed

Other solid neoplasm

Solid Tumors